KYTX INVESTOR ALERT: Kirby McInerney LLP Reminds Kyverna Therapeutics, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP notifies investors of the approaching February 7, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQ:KYTX) securities during the period from February 4, 2024, to December 9, 2024 (“the Class Period”). [LEARN MORE ABOUT THE CLASS ACTION] Kyverna’s lead product candidate is KYV-101. The Com ...